PARP Inhibitors as Monotherapy in Daily Practice for Advanced Prostate Cancers.
Teyssonneau D, Thiery-Vuillemin A, Dariane C, Barret E, Beauval JB, Brureau L, Créhange G, Fiard G, Fromont G, Gauthé M, Ruffion A, Renard-Penna R, Mathieu R, Sargos P, Rouprêt M, Ploussard G, Roubaud G, On Behalf Of The Cc-Afu Cancerology Committee Of The Association Française d'Urologie.
Teyssonneau D, et al. Among authors: dariane c.
J Clin Med. 2022 Mar 21;11(6):1734. doi: 10.3390/jcm11061734.
J Clin Med. 2022.
PMID: 35330059
Free PMC article.
Review.